Skip to content
healthcare.dev

rivaroxaban granule

NDC 70748-355, rivaroxaban granule, for suspension, from Lupin Pharmaceuticals, Inc..

Product NDC
70748-355
Status
Listed
Labeler
Lupin Pharmaceuticals, Inc.
Dosage form
FOR SUSPENSION
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA218195
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/70748-355 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • RIVAROXABAN155 mg/1

Pharmacologic classes

Factor Xa Inhibitor [EPC]; Factor Xa Inhibitors [MoA]

Package NDCNDC-11Package
70748-355-01707480355011 BOTTLE in 1 CARTON (70748-355-01) / 1 FOR SUSPENSION in 1 BOTTLE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/b0306b06-d8cf-48de-9e93-57d77e4e98f5
  • NADAC price for package 70748035501

    GET /v1/drugs/nadac/70748035501

Use it

Look up 70748-355 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/70748-355 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 70748-355. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.